Citi: Markedet undervurderer Darzalex’ potentiale

Storbanken Citi mener, at endnu en godkendelse i bæltet for Genmab og partneren Janssen med kræftmidlet Darzalex peger imod en endnu højere markedsandel for kræftmidlet end tidligere ventet.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and